Brain Mapping Instruments Market Analysis, Demand And Outlook 2025- 2034


Claim 20% Off With Code ONLINE20 – Explore Market Reports Covering Trade Trends, Regulatory Changes, and Growth Insights

What Is the Current Market Size and Growth Rate of the Brain Mapping Instruments Market?
The brain mapping instruments market size has grown strongly in recent years. It will grow from $2.27 billion in 2024 to $2.42 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to the increasing prevalence of neurological disorders, rise in demand for real-time brain monitoring, growth in clinical trials, growth of brain mapping in psychiatry, and expansion of telemedicine.

The brain mapping instruments market size is expected to see strong growth in the next few years. It will grow to $3.13 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing demand for advanced neuroimaging techniques, growing investments in neuroscience research, increasing adoption of non-invasive brain mapping technologies, growing number of clinical trials, and increasing demand for brain mapping in educational and cognitive development studies. Major trends in the forecast period include technological advancements, integration of virtual reality, personalized medicine, non-invasive brain mapping techniques, and cloud computing.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18270&type=smp

Which Factors Are Driving Growth in the Brain Mapping Instruments Market?
An increase in the prevalence of neurological disorders is expected to propel the growth of the brain mapping instrument market going forward. Neurological disorders are conditions affecting the brain, spinal cord, and nerves, leading to symptoms such as movement issues, cognitive decline, and sensory problems, examples including Alzheimer's, Parkinson's, epilepsy, multiple sclerosis, and stroke. The increasing prevalence of neurological disorders is due to population aging, urbanization, lifestyle changes, improved diagnostic capabilities, and environmental and infectious risk factors. Brain mapping instruments are essential in clinical practice and research, enabling deeper insights into neurological disorders and guiding personalized treatment strategies. For instance, in March 2023, according to the Alzheimer’s Association, a US-based non-profit voluntary health organization, in the United States, an estimated 6.7 million Americans aged 65 and older were living with Alzheimer's dementia, which is a neurological disorder. Further, by 2060, the number of people aged 65 and older with Alzheimer's dementia is projected to increase to 13.8 million. Therefore, the increase in the prevalence of neurological disorders drives the growth of the brain mapping instrument market.

What Are the Core Segments Shaping the Brain Mapping Instruments Market Landscape?
The brain mapping instrumentsmarket covered in this report is segmented –

1) By Product: Computed Axial Tomography (CAT), Positron Emission Tomography, Electroencephalography (EEG), Functional Near-Infrared Spectroscopy (FNIRS), Functional Magnetic Resonance Imaging (FMRI), Other Products
2) By Procedure: Devices For Invasive Procedures, Devices For Non-invasive Procedures
3) By End User: Hospitals, Ambulatory Centers

Subsegments:
1) By Computed Axial Tomography (CAT): Conventional CT Scanners, High-Resolution CT Scanners, Portable CT Scanners
2) By Positron Emission Tomography (PET): PET Scanners (Standalone), Hybrid PET/CT Scanners, PET/MRI Scanners
3) By Electroencephalography (EEG): Digital EEG Systems, Ambulatory EEG Systems, Video EEG Monitoring Systems
4) By Functional Near-Infrared Spectroscopy (FNIRS): Continuous Wave Fnirs Systems, Frequency Domain Fnirs Systems, Hybrid Fnirs Systems
5) By Functional Magnetic Resonance Imaging (FMRI): Resting-State Fmri, Task-Based Fmri, High-Field MRI Systems
6) By Other Products: Magnetoencephalography (MEG) Systems, Near-Infrared Spectroscopy (NIRS) Devices, Transcranial Magnetic Stimulation (TMS) Systems


What Are the Top Trends Expected to Shape the Brain Mapping Instruments Market by 2029?
Major companies operating in the brain mapping instrument market are focusing on developing innovative products, such as brain mapping devices, to enhance diagnostic accuracy and treatment efficacy in neurological disorders. Brain mapping devices refer to instruments used to visualize and analyze the structure and function of the brain. These devices employ various techniques such as magnetic resonance imaging (MRI), functional MRI (fMRI), electroencephalography (EEG), magnetoencephalography (MEG), and positron emission tomography (PET). For instance, in August 2022, IBS Hospital, an India-based hospital specializing in Neurology, launched Quicktome, the first brain mapping device. This innovative technology integrates advanced MRI and EEG capabilities with real-time functional imaging, offering unprecedented precision in visualizing brain structure and activity. Its key features include high-resolution imaging for detailed anatomical mapping, simultaneous EEG recording for comprehensive neural activity monitoring, and functional MRI for dynamic brain function analysis.

Which Are the Top Companies in the Brain Mapping Instruments Market?
Major companies operating in the brain mapping instruments market are Siemens Healthineers, GE Healthcare, Ricoh Company Ltd., Philips Healthcare, Bio-Rad Laboratories Inc., Elekta AB, Nihon Kohden Corporation, Brainlab AG, Natus Medical Incorporated, Hitachi Medical Systems, Canon Medical Systems Corporation, Compumedics Limited, Medtronic PLC, Laureate Digital Securities Pvt Ltd., Magstim Company Limited, EB Neuro S.p.A., Brain Products GmbH, Soterix Medical Inc., Rogue Research Inc., NIRx Medical Technologies LLC, Neurosoft, Artinis Medical Systems, Gowerlabs Ltd.

Get the full brain mapping instruments market report here:
https://www.thebusinessresearchcompany.com/report/brain-mapping-instruments-global-market-report

Which Regions Are Driving the Most Demand in the Brain Mapping Instruments Market?
North America was the largest region in the brain mapping instruments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain mapping instruments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more